The Oncology Institute logo

Latest News

The Oncology Institute Names Mihir Shah as Chief Financial Officer

Mihir Shah Preview Image

Shah Brings 15 Years of Financial Leadership in Public and Private Healthcare Companies

CERRITOS, Calif., April 04, 2022 (GLOBE NEWSWIRE) — The Oncology Institute of Hope and Innovation (NASDAQ: TOI) today announced the appointment of Mihir Shah as chief financial officer, effective immediately. In this role, Mr. Shah will lead the Accounting, Finance, Revenue Cycle Management, and Investor Relations functions, playing a key role in driving TOI’s public company success and executing the strategic growth plan. Mr. Shah succeeds Scott Dalgleish, who will serve as a senior advisor through a transition period.

Mr. Shah joins TOI with fifteen years of industry leadership experience across public, private, and not-for-profit organizations. Most recently Mr. Shah served as chief financial officer for Commonwealth Care Alliance (“Commonwealth”), an integrated healthcare organization, where he led key business initiatives for a company with more than $2 billion in annual revenue. Prior to Commonwealth, Mr. Shah served as chief financial officer for Apollo Medical Holdings, Inc. (NASDAQ: AMEH) and Unitek Information Systems, and has held progressive leadership roles at Arcadian Health Plan, now a part of Humana, helping to solve problems across strategy, finance, and rapid growth.

“I’m very pleased to welcome Mihir to the TOI team,” shared Brad Hively, chief executive officer at TOI. “He brings significant public company experience, as well as deep experience with value-based care, and I am confident that his deep knowledge and expertise will greatly benefit TOI as we expand our national footprint. We appreciate Scott’s contributions to building our financial infrastructure and his support of our continued growth. We look forward to executing a seamless transition together.”

“This is an exciting time for TOI, and I’m thrilled to join this team of talented and passionate leaders and clinicians dedicated to changing oncology care for the better,” said Shah. “As chief financial officer, I feel privileged to have the opportunity to serve TOI’s customers, teammates, community, and shareholders and look forward to this company’s continued success.”

About The Oncology Institute

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.6 million patients including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 80+ employed clinicians and more than 600 teammates in 50 clinic locations and growing, TOI is changing oncology for the better. For more information, visit www.theoncologyinstitute.com.

Skip to content